Equity Profile

COR

Cencora, Inc.

Health CareHealth Care Distributors$59.6B

May6Wed

Post-Earnings Recap

ReportedQ2-2026Pre-Market6:30 AM EDT

Cencora, Inc. Misses on EPS, Stock Down 17.38%

Metric	Actual	Expected	Surprise
EPS	$4.75	N/A	-1.04%
Revenue	N/A	N/A	N/A

management commentary, guidance changes, and full analysis available with Pro.

Cencora, Inc. Misses on EPS, Stock Down 17.38%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$4.75	N/A	-1.04%
Revenue	N/A	N/A	N/A

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

What It Means

Cencora, Inc. reported an EPS of $4.75, slightly missing expectations. The stock reacted negatively, dropping 17.38%, likely due to investor disappointment over the earnings miss and lack of revenue information.

Company Snapshot

Cencora, Inc. operates in the health care sector, specifically as a distributor of medical products and services....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

$4.07

Revenue Growth

Revenue growth reflects the company's ability to expand its business and meet market demand.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Cencora, Inc. operates in the health care sector, specifically as a distributor of medical products and services. With a market cap of $59 billion, the company plays a crucial role in ensuring that health care providers have access to necessary supplies, which is vital for patient care and overall health outcomes.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+3.76%

Avg Stock Reaction

-1.64%

Last Quarter Recap

In the last quarter, Cencora reported an EPS of $4.08, slightly beating estimates. However, the stock declined by 8.79% the following day, indicating potential investor concerns despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for Cencora's upcoming earnings are mixed, with no analyst estimates available. Investors will be keen to see if the company can maintain its track record of beating EPS estimates.

Bull Case

The optimistic view hinges on Cencora continuing its trend of EPS beats, potentially driven by strong demand for health care products and efficient cost management.

Bear Case

On the flip side, concerns about rising costs or supply chain issues could lead to disappointing results, especially if revenue growth does not meet expectations.

Key Metrics to Watch

EPS (Earnings Per Share)

$4.07

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its business and meet market demand.

Gross Margin

N/A

Gross margin indicates how efficiently the company is producing its products and managing costs.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Cencora's EPS exceed $4.07?

Given the company's history of beating EPS estimates, this number will be crucial for investor confidence.

What are the revenue growth figures for this quarter?

Revenue growth is essential for understanding the company's market position and ability to sustain profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Cencora's ability to maintain high EPS due to its strong operational efficiencies and market position.

Supporting Evidence

Cencora has consistently beaten EPS estimates in the past, indicating strong management performance.

The options market is pricing in a larger move than historical averages, suggesting that investors expect significant news.

Despite recent stock price declines, the company's fundamentals remain strong.

Key Risk

If EPS comes in below $4.00, it could lead to a significant reevaluation of the company's growth prospects.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Cencora can maintain its profitability amid rising costs and supply chain challenges.

Bull Confirmed If

An EPS of $4.10 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $4.00 would confirm the bear case, raising concerns about the company's profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±5.56%

Historical Avg

±5.6%

In line with history

The options market is pricing in a significant move, suggesting that investors are anticipating volatility around the earnings announcement.

Options are pricing ±6.5% while COR has averaged ±5.6% over the last 8 prints — setup is roughly in line with history.

Detail

ATM IV

0.5%

30d HV

21.1%

Calls (8K)P/C Ratio: 1.14Puts (113K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: X of Y (Z%)

This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 4.6%, with a raw directional average of +0.8% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cencora beats expectations and raises guidance, history suggests the stock could react positively, averaging a +0.02% move on beats.

In-Line / Cautious

If the results are in line with expectations but management provides cautious commentary, the stock may see a muted reaction.

Miss

Should the company miss expectations, history indicates a potential downside move, averaging -2.93% on misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on supply chain management and cost control measures.
2Details on revenue growth and demand for health care products.
3Management's outlook on future earnings and market conditions.
4Insights into operational efficiencies and margin improvements.
5Responses to any analyst questions regarding competitive pressures.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

Cencora, Inc. operates in the health care sector, specifically as a distributor of medical products and services....

Key Metrics to Watch

EPS (Earnings Per Share)

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

$4.07

Revenue Growth

Revenue growth reflects the company's ability to expand its business and meet market demand.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+3.76%

Avg Stock Reaction

-1.64%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

The optimistic view hinges on Cencora continuing its trend of EPS beats, potentially driven by strong demand for health care products and efficient cost management.

Bear Case

On the flip side, concerns about rising costs or supply chain issues could lead to disappointing results, especially if revenue growth does not meet expectations.

Key Metrics to Watch

EPS (Earnings Per Share)

$4.07

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its business and meet market demand.

Gross Margin

N/A

Gross margin indicates how efficiently the company is producing its products and managing costs.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Cencora's EPS exceed $4.07?

Given the company's history of beating EPS estimates, this number will be crucial for investor confidence.

What are the revenue growth figures for this quarter?

Revenue growth is essential for understanding the company's market position and ability to sustain profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Cencora's ability to maintain high EPS due to its strong operational efficiencies and market position.

Supporting Evidence

Cencora has consistently beaten EPS estimates in the past, indicating strong management performance.

The options market is pricing in a larger move than historical averages, suggesting that investors expect significant news.

Despite recent stock price declines, the company's fundamentals remain strong.

Key Risk

If EPS comes in below $4.00, it could lead to a significant reevaluation of the company's growth prospects.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Cencora can maintain its profitability amid rising costs and supply chain challenges.

Bull Confirmed If

An EPS of $4.10 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $4.00 would confirm the bear case, raising concerns about the company's profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±5.56%

Historical Avg

±5.6%

In line with history

The options market is pricing in a significant move, suggesting that investors are anticipating volatility around the earnings announcement.

Options are pricing ±6.5% while COR has averaged ±5.6% over the last 8 prints — setup is roughly in line with history.

Detail

ATM IV

0.5%

30d HV

21.1%

Calls (8K)P/C Ratio: 1.14Puts (113K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: X of Y (Z%)

This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 4.6%, with a raw directional average of +0.8% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cencora beats expectations and raises guidance, history suggests the stock could react positively, averaging a +0.02% move on beats.

In-Line / Cautious

If the results are in line with expectations but management provides cautious commentary, the stock may see a muted reaction.

Miss

Should the company miss expectations, history indicates a potential downside move, averaging -2.93% on misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on supply chain management and cost control measures.
2Details on revenue growth and demand for health care products.
3Management's outlook on future earnings and market conditions.
4Insights into operational efficiencies and margin improvements.
5Responses to any analyst questions regarding competitive pressures.